Statins may cut liver cancer risk for diabetics

	Tweet

People with diabetes run a higher-than-normal risk of developing liver caner, but it seems that taking the popular “statin” cholesterol-lowering drugs may reduce that risk, researchers report.

The impact of Statins on liver cancer has been unclear, Dr. Hashem B. El-Serag and colleagues note in the medical journal Gastroenterology. There is some evidence that the drugs may help prevent or slow liver cancer progression, but also that they might promote liver cancer—at least in lab animals.

To look into the issue, El-Serag, from Baylor College of Medicine, Houston, and colleagues assessed statin use by 1303 people with diabetes who developed liver cancer and in 5212 diabetics who did not. 

Nearly all of the subjects were men and their average age was 72 years.

Overall, significantly fewer of the patients with liver cancer than those without liver cancer had filled at least one prescription for a statin: 34 percent vs. 53 percent.

The researchers say this is the first indication that Statins have a cancer-preventive effect specific to liver cancer. However, they conclude, “These findings need to be confirmed in future studies.”

SOURCE: Gastroenterology, June 2009.

RELATED STORIES:
Studies of patients with cirrhosis uncover limitations in liver cancer screening   Wilmot Researchers Create New Way to Study Liver Cancer   Liver cancer in cirrhotic patients effectively treated with radiofrequency ablation   Scientists identify specific markers that trigger aggressiveness of liver cancer   Saffron shows promise in preventing liver cancer   Researchers find gene to fight liver cancer   Sex hormone explains men’s higher liver cancer risk   Liver transplant recipients almost 3 times more likely to develop cancer   Experts find rogue stem cells in liver cancer   Eating mandarins reduces the risk of liver disease, hardened arteries and insulin resistance   More evidence coffee may cut risk of liver cancer   The ignored virus that causes liver cancer   Researchers Identify Gene Linked to Aggressive Progression of Liver Cancer   Personalized treatment may help some liver cancer patients   More Reliable Biomarkers Needed for Liver Cancer Detection   Researchers Find That Targeted Therapy Combination Overcomes Treatment Resistance in Liver Cancer   Metformin May Protect Against Liver Cancer   Liver cancer patients less likely to die on wait list than candidates without carcinomas   Combination Therapy Improves Survival Time For Patients With Advanced Liver Cancer   New study confirms link between nonalcoholic steatohepatitis and liver cancer   Mayo Clinic Studies Identify Risk Factors in Rising Trend of Liver Cancer   Racial disparities evident in early-stage liver cancer survival

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]